804 Real-world incidence and impact of pneumonitis in lung cancer patients treated with immune checkpoint inhibitors

by Ryan Sullivan, Leyre Zubiri, Kerry Reynolds, Vartan Pahalyants, Nicholas Theodosakis, Yevgeniy Semenov, Bruce Tiu, James Iheke, Pearl Ugwu-Dike, Jayhyun Seo, Kimberly Tang, Meghan Mooradian
Published 2021-11-01

814 Cutaneous immune-related adverse events are protective of mortality in patients treated with anti-PD1 and anti-PDL1 therapy in a multi-institutional cohort study

by Nicole LeBoeuf, Leyre Zubiri, Kerry Reynolds, Vartan Pahalyants, Yevgeniy Semenov, Vivek Naranbhai, Alexander Gusev, Shawn Kwatra, Thomas Le, Bruce Tiu, Pearl Ugwu-Dike, Jayhyun Seo, Kimberly Tang, Neel Raval, Maryam Asgari
Published 2021-11-01

Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study

by Jarushka Naidoo, Ryan Sullivan, Meghan J Mooradian, Leyre Zubiri, Vartan Pahalyants, Nicholas Theodosakis, Kerry L Reynolds, Yevgeniy R Semenov, Meghan E Sise, James Iheke, Pearl Ugwu-Dike, Jayhyun Seo, Kimberly Tang, Bruce C Tiu
Published 2022-06-01